Advertisement

CQ50. Is Serum Thyroglobulin Measurement Useful as a Marker of Carcinoma Recurrence After Surgery?

  • Minoru Fujimori
  • Hisato Hara
  • Hidemitsu Tsutsui
Chapter

Abstract

Thyroglobulin is a chief constituent of colloid in the thyroid follicles, which is vital for the synthesis of thyroid hormone. The serum thyroglobulin level of healthy people is around 30 ng/ml, but it decreases to nearly zero when thyroid tissue does not remain after total thyroidectomy. Whether thyroglobulin measurement is useful as a marker of recurrence after surgery for differentiated carcinoma is examined.

Keywords

Thyroid Hormone Thyroid Carcinoma Total Thyroidectomy Thyroid Tissue Differentiate Thyroid Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Takami H (2005) (Text in Japanese) Gan to Kagakuryoho 32:561–565 (NR)Google Scholar
  2. 2.
    Hamy A, Mirallie E, Bennouna J et al (2004) Thyroglobulin monitoring after treatment of well-differentiated thyroid cancer. Eur J Surg Oncol 30:681–685 (RS)PubMedCrossRefGoogle Scholar
  3. 3.
    Mazzaferri EL, Robbins RJ, Spencer CA et al (2003) A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 88:1433–1441 (SR<RCT>)PubMedCrossRefGoogle Scholar
  4. 4.
    Spencer CA, Takeuchi M, Kazarosyan M et al (1998) Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 83:1121–1127 (SR<RCT>)PubMedCrossRefGoogle Scholar
  5. 5.
    Cooper DS, Doherty GM, Haugen BR et al (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109–142 (Others)PubMedCrossRefGoogle Scholar
  6. 6.
    Heemstra KA, Liu YY, Stokkel M et al (2007) Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma. Clin Endocrinol 66:58–64 (RS)Google Scholar

Copyright information

© Springer Japan 2013

Authors and Affiliations

  • Minoru Fujimori
    • 1
  • Hisato Hara
    • 2
  • Hidemitsu Tsutsui
    • 3
  1. 1.Department of Breast SurgeryTokyo Medical University, Ibaraki Medical CenterAmimachi, InashikigunJapan
  2. 2.Department of Breast and Endocrine Surgery, Clinical Science, Graduate School of Comprehensive Human SciencesUniversity of TsukubaTsukubaJapan
  3. 3.Department of Thoracic and Thyroid SurgeryTokyo Medical UniversityTokyoJapan

Personalised recommendations